MedPath

Fetoscopic Tracheal Balloon Occlusion in Left Diaphragmatic Hernia

Phase 2
Conditions
Diaphragmatic Hernia
Interventions
Procedure: Fetoscopic tracheal balloon occlusion
Registration Number
NCT00373438
Lead Sponsor
University Hospital, Bonn
Brief Summary

Left diaphragmatic hernia detected during fetal life carries a high risk for postnatal lung failure due to lung underdevelopment and pulmonary hypertension. In severe cases, extracorporeal membrane oxygenation (ECMO) is used as a life-saving intensive care means to enable survival of severely affected infants.

Clinical experience from prospective controlled non-randomized case series with fetoscopic tracheal balloon occlusion has seen improved survival rates in contrast to untreated controls.

Therefore, the purpose of this randomized clinical trial in a less severely affected subgroup of patients is whether by fetoscopic tracheal occlusion, the intensity of postnatal intensive care therapy might be reduced. Primary outcome measure is the need for postnatal ECMO therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
98
Inclusion Criteria
  • Pregnant women from European countries carrying fetuses with left diaphragmatic hernia.
  • Normal karyotype, no further severe anomalies on prenatal ultrasound study.
  • Fetal liver herniation into the chest; gestational age-related lung volume between 20-25% of normal as determined by magnetic resonance imaging between 30+0 - 34+0 weeks+days of gestation.
Exclusion Criteria
  • Any maternal disease or condition that would result in an increased risk to her health from the experimental procedure.
  • Abnormal fetal karyotype, further severe fetal anomalies on prenatal ultrasound.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AFetoscopic tracheal balloon occlusion-
BFetoscopic tracheal balloon occlusionFetoscopic tracheal occlusion
Primary Outcome Measures
NameTimeMethod
Need for postnatal ECMO therapyFirst two days of life
Secondary Outcome Measures
NameTimeMethod
Survival to discharge from hospitalDays to discharge
Maternal morbidityUntil maternal discharge
Fetal / Neonatal morbidityOverall & at discharge from hospital
Premature preterm rupture of membranesFollowing the interventions over the remainder of gestation
Unintended preterm deliveryFollowing the interventions before scheduled elective delivery
Days in intensive careNumber of day until discharge from ICU
Days in hospitalNumber of days until discharge from hospital
Oxygen dependency on dischargeDays until discharge

Trial Locations

Locations (1)

German Center for Fetal Surgery & Minimally Invasive Therapy

🇩🇪

Bonn, Germany

© Copyright 2025. All Rights Reserved by MedPath